• 1
    Davies JV, Sharp NJH. A comparison of conservative treatment and fenestration for thoracolumbar disc disease in the dog. J Small Anim Pract 1983;24:721729.
  • 2
    Butterworth SJ, Denny HR. Follow-up of 100 cases with thoracolumbar disc protrusions treated by lateral fenestration. J Small Anim Pract 1991;32:443447.
  • 3
    Duval J, Dewey C, Roberts R, Aron D. Spinal cord swelling as a myelographic indicator of prognosis: A retrospective study in dogs with interverterbral disc disease and loss of deep pain perception. Vet Surg 1996;25:612.
  • 4
    Wheeler SJ, Sharp NJH. Small Animal Spinal Disorders. Diagnosis and Surgery. London : Mosby-Wolfe;1994: 171191.
  • 5
    Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methyl-prednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med 1990;322:14051411.
  • 6
    Bracken MB, Shepard MJ, Collins WF, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. J Neurosurg 1992;76:2331.
  • 7
    Wrathall JR, Pettegrew RK, Harvey F. Spinal cord contusion in the rat: Production of graded, reproducible, injury groups. Exp Neurol 1985;88:108122.
  • 8
    Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977;47:577581.
  • 9
    Watson BD, Prado R, Dietrich WD, et al. Photochemically induced spinal cord injury in the rat. Brain Res 1986;367:296300.
  • 10
    Khan M, Griebel R. Acute spinal cord injury in the rat: Comparison of three experimental techniques. Can J Neurol Sci 1983;10:161165.
  • 11
    Cheng H, Cao Y, Olson L. Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function. Science 1996;273:510513.
  • 12
    Bregman BS, Kunkel-Bagden E, Reier PJ, et al. Recovery of function after spinal cord injury: Mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp Neurol 1993;123:316.
  • 13
    Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplantation of olfactory ensheathing cells. Science 1997; 277:20002002.
  • 14
    Zompa EA, Cain LD, Everhart AW, et al. Transplant therapy: Recovery of function after spinal cord injury. J Neurotrauma 1997;14:479506.
  • 15
    Janssens LAA. Mechanical and pathophysiological aspects of acute spinal cord trauma. J Small Anim Pract 1991;32:527579.
  • 16
    Coughlan AR. Secondary injury mechanisms in acute spinal cord trauma. J Small Anim Pract 1993;34:117122.
  • 17
    Braund KG, Shores A, Brawner WR. The etiology, pathology, and pathophysiology of acute spinal cord trauma. Vet Med 1990;85:684691.
  • 18
    Kraus KH. The pathophysiology of spinal cord injury and its clinical implications. Semin Vet Med Surg 1996; 11:201207.
  • 19
    Jeffrey NH. Pathophysiology of spinal cord trauma. Chapter 3. In: Handbook of Small Animal Spinal Surgery. London : WB Saunders; 1995: 6484.
  • 20
    Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:1526.
  • 21
    Griffiths IR. Vasogenic edema following acute and chronic spinal cord compression in the dog. J Neurosurg 1975;42:155165.
  • 22
    Sandier AN, Tator CH. Effect of acute spinal cord compression injury on regional spinal cord blood flow in primates. J Neurosurg 1976;45:660676.
  • 23
    Senter HJ, Venes JL. Altered blood flow and secondary injury in experimental spinal cord trauma. J Neurosurg 1978;49:569578.
  • 24
    Rawe SE, Perot PL. Pressor response resulting from experimental contusion injury to the spinal cord. J Neurosurg 1979;50:5863.
  • 25
    Guha A, Tator CH. Acute cardiovascular effects of experimental spinal cord injury. J Trauma 1988;28:481490.
  • 26
    Balentine JD. Pathology of experimental spinal cord trauma I. The necrotic lesion as a function of vascular injury. Lab Invest 1978;39:236253.
  • 27
    Dow-Edwards D, DeCrescito V, Tomasula JJ, Flamm ES. Effect of aminophylline and isoproterenol on spinal cord blood flow after impact injury. J Neurosurg 1980;53:385390.
  • 28
    Fehlings MG, Tator CH, Linden RD. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989;71:403416.
  • 29
    Hall ED, Wolf DL. A pharmacological analysis of the patho-physiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg 1986;64:951961.
  • 30
    Ducker TB, Salcman M, Perot PL, Ballantine D. Experimental spinal cord trauma, I: Correlation of blood flow, tissue oxygen and neurologic status in the dog. Surg Neurol 1978;10:6063.
  • 31
    Ducker TB, Salcman M, Lucas JT, et al. Experimental spinal cord trauma, II: Blood flow, tissue oxygen, evoked potentials in paretic and plegic monkeys. Surg Neurol 1978;10:6470.
  • 32
    Kobrine AI, Doule TF, Rizzoli HV. Spinal cord blood flow as affected by changes in systemic arterial pressure. J Neurosurg 1976; 44:1215.
  • 33
    Young W, DeCrescito V, Tomasula JJ. Effect of sympathectomy on spinal cord blood flow autoregulation and posttraumatic ischaemia. J Neurosurg 1982;56:706710.
  • 34
    Guha A, Tator CH, Rochon J. Spinal cord blood flow and systemic blood pressure after experimental spinal cord injury in rats. Stroke 1989;20:372377.
  • 35
    Dolan EJ, Tator CH. The effect of blood transfusion, dopamine and gamma hydroxybutyrate on posttraumatic ischemia of the spinal cord. J Neurosurg 1982;56:350358.
  • 36
    Guha A, Tator CH, Smith CR, Piper I. Improvement in posttraumatic spinal cord blood flow with a combination of a calcium channel blocker and a vasopressor. J Trauma 1989;29:14401447.
  • 37
    Young WF, Rosenwasser RH, Vasthare US, Tuma RF Preservation of post-compression spinal cord function by infusion of hyper-tonic saline. J Neurosurg Anesthesiol 1994;6:122127.
  • 38
    Rawe SE, Lee WA, Perot PL. The histopathology of experimental spinal cord trauma. The effect of systemic blood pressure. J Neurosurg 1978;48:10021007.
  • 39
    Alderman JL, Osterholm JL, D'Amore BR, et al. Influences of arterial blood pressure upon central hemorrhagic necrosis after severe spinal cord injury. Neurosurgery 1979;4:5355.
  • 40
    Salzman SK, Lee WA, Sabuto S, et al. Halothane anesthesia is neuroprotective in experimental spinal cord injury: Early hemodynamic mechanisms of action. Res Commun Chem Pathol Pharmacol 1993; 80:5981.
  • 41
    Faden AI. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury. Adv Neurol 1988;47:531546.
  • 42
    Young W, Flamm ES, Demopoulos HB, et al. Effect of naloxone on posttraumatic ischemia in experimental spinal contusion. J Neurosurg 1981;55:209219.
  • 43
    Stokes BT, Fox P, Hollinden G. Extracellular calcium activity in the injured spinal cord. Exp Neurol 1983;80:561572.
  • 44
    Young W, Koreh I. Potassium and calcium changes in injured spinal cords. Brain Res 1986;365:4253.
  • 45
    De Lay G, Laybaert L. Effect of flunarizine and methylpred-nisolone on functional recovery after experimental spinal injury. J Neurotrauma 1993;10:2535.
  • 46
    Pointillart V, Gense D, Gross C, et al. Effects of nimodipine on posttraumatic spinal cord ischemia in baboons. J Neurotrauma 1993; 10:201213.
  • 47
    Faden AI, Jacobs TP, Smith MT. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J Neurosurg 1984;60:796799.
  • 48
    Ford RW, Malm DN. Failure of nimodipine to reverse acute spinal cord injury. Cent Nerv Syst Trauma 1985;2:917.
  • 49
    Haghighi SS, Stiens T, Oro JJ, Madsen R. Evaluation of calcium channel antagonist nimodipine after experimental spinal cord injury. Surg Neurol 1993;39:403408.
  • 50
    Meintjes E, Hosgood G, Daniloff J. Pharmaceutic treatment of acute spinal cord trauma. Compend Cont Educ 1996;18:625635.
  • 51
    Demopoulos HB, Flamm ES, Pietronigro DD. The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand 1980;492:91119.
  • 52
    Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992;76:1322.
  • 53
    Brown SA, Hall ED. Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries. J Am Vet Med Assoc 1992;200:18491859.
  • 54
    Anderson DK, Waters TR, Means ED. Pretreatment with alpha tocopherol enhances neurologic recovery after experimental spinal cord compression. J Neurotrauma 1988;5:6167.
  • 55
    Means ED, Anderson DK, Waters TR, Kalaf L. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 1981;55:200208.
  • 56
    Braughler JM, Hall ED, Means ED, et al. Evaluation of an intensive methylprednisolone sodium succinate regimen in experimental spinal cord injury. J Neurosurg 1987;67:102105.
  • 57
    Behrmann DL, Bresnahan JC, Beattie MS. Modelling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol 1994;126:175.
  • 58
    Constantini S, Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg 1994;80:97111.
  • 59
    Hall ED, Yonkers PA, Taylor BM, Sun FE Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord. J Neurotrauma 1995;12:245256.
  • 60
    Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 1993;79:500507.
  • 61
    Scheff SW, Hoff SF, Anderson KJ. Altered regulation of lesion-induced synaptogenesis by adrenalectomy and corticosterone in young adult rats. Exp Neurol 1986;93:456470.
  • 62
    Jap Tjoen San ERA, Schmidt-Michels M, Oestreicher AB, et al. Dexamethasone-induced effects on B-50/GAP-43 expression and neurite outgrowth in PC12 cells. J Mol Neurosci 1992;3:189195.
  • 63
    Sapolsky RM. Glucocorticoids, stress and exacerbation of excitotoxic neuron death. Semin Neurosci 1994;6:323331.
  • 64
    Smith-Swintosky VL, Pettegrew LC, Sapolsky RM, et al. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 1996; 16:585598.
  • 65
    Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997;277:15971604.
  • 66
    Galandiuk S, Raque G, Appel S, Polk HC jr. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg 1993; 218:419425.
  • 67
    Coates JR, Sorjonen DC, Simpson ST, et al. Clinicopathologic effects of a 21-aminosteroid compound (U74389G) and high-dose methylprednisolone on spinal cord function after simulated spinal cord trauma. Vet Surg 1995;24:128139.
  • 68
    Siemering GB, Vomering ML. High dose methylprednisolone sodium succinate: An adjunct to surgery for canine intervertebral disc herniation. Vet Surg 1992; 21: 406, (abstract).
  • 69
    Hanson SM, Bostwick DR, Twedt DC, Smith MO. Clinical evaluation of cimetidine, sucralfate and misoprostol for prevention of gastrointestinal tract bleeding in dogs undergoing spinal surgery. Am J Vet Res 1997;58:13201323.
  • 70
    Hall ED. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. J Neurosurg 1988;68:462465.
  • 71
    Anderson DK, Braughler JM, Hall ED, et al. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J Neurosurg 1988;69:562567.
  • 72
    Holtz A, Gerdin B. Blocking weight-induced spinal cord injury in rats: Therapeutic effect of the 21-aminosteroid U74006F. J Neurotrauma 1991;8:239245.
  • 73
    Hoerlein BF, Redding RW, Hoff EJ, McGuire JA. Evaluation of dexamethasone, DMSO, mannitol, and solcoseryl in acute spinal cord trauma. J Am Anim Hosp Assoc 1983;19:216225.
  • 74
    Faden AI, Jacobs TP, Smith MT, Holaday JW. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury. Neurology 1983;33:673678.
  • 75
    Zileli M, Ovul I, Dalbasti T. Effects of methyl prednisolone, dimethyl sulfoxide and naloxone in experimental spinal cord injury in rats. Neurol Res 1988;10:232235.
  • 76
    Parker AJ, Smith CW. Lack of functional recovery from spinal cord trauma following dimethylsulfoxide and epsilon amino caproic acid therapy in dogs. Res Vet Sci 1979;27:253255.
  • 77
    Kajihara K, Kawanga H, de la Torre J, Mullan S. Dimethyl sulfoxide in the treatment of experimental spinal cord injury. Surg Neurol 1973; 1:1622.
  • 78
    Kassell NF, Sprowell JA, Boarini DJ, Olin JJ. Effect of dimethyl sulfoxide on the cerebral and systemic circulations of the dog. Neurosurgery 1983;12:2428.
  • 79
    Choi DW. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988; 11:465469.
  • 80
    Choi DW, Maulucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987;7:357368.
  • 81
    Olby NJ, Sharp NDH, Munana KR, Papich MG. Chronic and acute compressive spinal cord lesions in dogs are associated with increased lumbar CSF glutamate levels. J Vet Intern Med 1999; 13: 240 (abstract).
  • 82
    Gomez-Pinella F, Tram H, Cotman CW, Nieto-Sampedro M. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp Neurol 1989;104:118124.
  • 83
    Faden AI, Lemke M, Simon RP, Noble LJ. W-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: Behavioural, anatomic, and neurochemical studies. JNeurotrauma 1988;5:3345.
  • 84
    Pencalet P, Ohanna F, Poulat P, et al. Thienyl-phencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury. J Neurosurg 1993;78:603609.
  • 85
    Wrathall JR, Choiniere D, Dong Teng Y. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 1994;14:65986607.
  • 86
    Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:13601362.
  • 87
    Faden AI, Jacobs TP, Mougey E, Holaday JW. Endorphins in experimental spinal injury: Therapeutic effect of naloxone. Ann Neurol 1981; 10; 326332.
  • 88
    Faden AI, Jacobs TP, Holaday JW. Opiate antagonist improves neurologic recovery after spinal injury. Science 1981;211:493494.
  • 89
    Faden AI. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann Neurol 1990;27:6774.
  • 90
    Behrmann DL, Bresnahan JC, Beattie MS. A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat. Exp Neurol 1993;119:258267.
  • 91
    Hall ED, Wolf DL, Althaus JS, Von Voigt-Lander PE. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Brain Res 1987;435:174180.
  • 92
    Hayward NJ, McKnight AT, Woodruff GN. Neuroprotective effect of the K-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia. Eur J Neurosci 1993;5:961967.
  • 93
    Olby NJ, Jeffrey ND, Blakemore WE. Trial of the efficacy of the kappa opioid agonist, enadoline, at limiting the extent of tissue damage that develops following photochemically-induced injury. Exp Neurol 1999. Submitted.
  • 94
    Lux WE, Feuerstein G, Faden AI. Alteration of leukotriene D4 hypotension by thyrotropin-releasing hormone. Nature 1983;302:822824.
  • 95
    Lux WE, Feuerstein G, Snyder F, Faden AI. Effect of thyrotropin-releasing hormone on hypotension produced by platelet-activating factor. Circ Shock 1983;10:262.
  • 96
    Renaud LP, Blumne HW, Pittman QJ, et al. Thyrotropin-releasing hormone selectively depresses glutamate excitation of cerebral cortical neurons. Science 1979;205:12751276.
  • 97
    Faden AI, Jacobs TP, Smith MT. Thyrotropin-releasing hormone in experimental spinal cord injury. Dose response and late treatment. Neurology 1984;34:12801284.
  • 98
    Hashimoto T, Fukada N. Effect of thyrotropin-releasing hormone on the neurologic impairment in rats with spinal cord injury: Treatment starting 24 hours and 7 days after injury. Eur J Pharmacol 1991;23:2532.
  • 99
    Hoerlein BF, Redding RW, Hoff EJ, McGuire JA. Evaluation of naloxone, crocetin, thyrotropin-releasing hormone, methylprednisolone, partial myelotomy and hemilaminectomy in the treatment of acute spinal cord trauma. J Am Anim Hosp Assoc 1985;2:6777.
  • 100
    Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 1995;12:235243.
  • 101
    Fox GB, Faden AI. A novel cyclic dipeptide analog of a TRH derivative exhibits neuroprotective and neurotropic properties following traumatic brain injury in the rodent. Soc Neurosci Abstr 1998;24: 1728.
  • 102
    Rothwell NJ, Relton JK. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Behav Rev 1993;17:217227.
  • 103
    Perry VH, Andersson P-B, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci 1993; 16: 268272.
  • 104
    Giulian D, Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993;24:8490.
  • 105
    Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: Intrinsic immunoeffector cell of the brain. Brain Res Rev 1995;20:269287.
  • 106
    Blight AR, Cohen TI, Saito K, Heyes MP Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 1995;118:735752.
  • 107
    Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994;6:712724.
  • 108
    Blight AR. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioural evidence of delayed secondary pathology. J Neurol Sci 1991;103:156171.
  • 109
    Olby NJ, Blakemore WE. Primary demyelination and regeneration of ascending axons in the dorsal funiculus of the rat spinal cord following photochemically-induced injury. J Neurocytol 1996;25:465480.
  • 110
    Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997;3:7376.
  • 111
    Blight AR. Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 1994;60:263273.
  • 112
    Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischaemic injury in the spinal cord. Ann Neurol 1990;27:3342.
  • 113
    Taoka Y, Okajima K, Uchiba M, et al. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats. Crit Care Med 1997;25:874879.
  • 114
    Taoka Y, Okajima K, Uchiba M, et al. Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analogue. J Neurosurg 1997;86:10071011.
  • 115
    Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits neuronal damage induced by cerebral ischaemia or NMDA-receptor activation in the rat. Brain Res Bull 1992;585:135160.
  • 116
    Bartholdi D, Schwab ME. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study. Eur J Neurosci 1997;9:14221438.
  • 117
    Guth L, Zhang Z, Roberts E. Key role for pregnolone in combination therapy that promotes recovery after spinal cord injury. Proc Natl Acad Sci USA 1994;91:1230812312.
  • 118
    Skaper SD, Leon A. Monosialogangliosides, neuroprotection and neuronal repair processes. J Neurotrauma 1992; 9 (Suppl 2): 507516.
  • 119
    Geisler FH, Dorsey FC, Coleman WE Recovery of motor function after spinal-cord injury—A randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 1991;324:18291838.
  • 120
    Geisler FH, Dorsey FC, Paternello F, et al. Sygen (GM1-ganglioside) acute spinal cord injury study. Congress of Neurosurgical Surgeons, Seattle, WA, October 8, 1998.
  • 121
    Ginsberg MD, Sternau L, Globus MY-T, et al. Therapeutic modulation of brain temperature: Relevance to ischemic brain injury. Cereb Blood Flow Metab 1992;4:189225.
  • 122
    Martinez-Arizala A, Green B. Hypothermia in spinal cord injury. J Neurotrauma 1992;9(Suppl 2):497505.
  • 123
    Bullock R, Chestnut RM, Clifton G, et al. In Guidelines for the Management of Severe Head Injury. New York , NY : Brain Trauma Foundation; 1997: 5.
  • 124
    Francel PC, Long BA, Malik JM, et al. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage. J Neurosurg 79:742751.
  • 125
    Griffiths IR, Pitts LH, Crawford RA, Trench JG. Spinal cord compression and blood flow. I. The effects of raised cerebrospinal fluid pressure on spinal cord blood flow. Neurology 1978;28:11451151.